Yardi Voyager vs MRI Software vs ARGUS Enterprise?

01

What each platform is and who owns them

The ownership structures matter for procurement. Yardi is founder-led and famously reluctant to publish list pricing, negotiations are highly relationship-driven. MRI is PE-owned and more transparent on commercial terms but has expanded via acquisition, so the product suite is a patchwork. Altus (ARGUS) is a public company with predictable pricing and a narrower product footprint focused on valuation and forecasting. Understanding who owns each platform explains a lot about how they behave in an RFP.

02

Yardi Voyager, strengths, weaknesses, pricing model

Yardi's strength is breadth. If you run a mixed portfolio with residential, commercial, and affordable housing, Yardi covers all of it in one stack, which reduces integration burden. The weakness is that the platform can feel dated in UX and requires significant configuration to run efficiently. Pricing typically lands in the low to mid six figures annually for a $500M portfolio, with add-on modules pushing costs materially higher. Implementation partners are essential.

03

MRI Software, strengths, weaknesses, pricing model

MRI's positioning is the open-platform counter to Yardi's closed ecosystem. That plays well for funds that want to pick best-of-breed tools rather than commit to a single vendor's full suite. The weakness is that the product surface is fragmented due to acquisitions, and different modules feel like different products. Pricing is typically comparable to Yardi in the low to mid six figures for a $500M portfolio, sometimes lower on entry and higher on add-ons.

04

ARGUS Enterprise, what it does and what it does not do

ARGUS is the tool that LPs, appraisers, and lenders expect to see the underwriting in. Its models are the de facto language of commercial real estate valuation. What ARGUS does not do is run your general ledger, process rent, manage leases operationally, or provide investor reporting on its own. That is why almost every institutional operator runs ARGUS alongside Yardi or MRI, not instead of.

05

Feature-by-feature comparison

In practice the feature map looks like this. Accounting, leasing, and operations are Yardi vs MRI. Valuation and forecasting are ARGUS on its own tier, with Yardi Forecast Manager and MRI valuation modules as lighter alternatives. Dashboards and investor-facing reporting are underserved by all three, which is why Snowflake plus Tableau or Power BI, or a custom dashboard, sits on top of the stack. Assuming any single vendor covers everything at institutional grade is the most common mistake in RFPs.

06

Pricing at portfolio scale

Pricing scales with unit count, user count, and module footprint, not with AUM directly, but AUM is a reasonable proxy for a given asset class. Yardi and MRI both discount aggressively on multi-year commitments and reward bundle expansion, which is why the sticker cost and the effective cost often diverge. ARGUS is the most predictable line item because pricing is largely per-user. Total cost of ownership including internal FTEs, implementation partners, and BI tooling typically runs two to three times the license fee.

07

Which platform fits which fund structure

The right sequencing depends on where the operating complexity sits. A value-add fund with 8-15 assets and a 5-year hold does most of its work in ARGUS, the underwriting model is the source of truth, and accounting can run on a lighter stack. A core REIT with 200+ properties and long holds needs the full operational depth of Yardi or MRI, and ARGUS becomes the valuation overlay. Family offices sit at the low-complexity end and can defer the platform decision until the portfolio justifies it.

08

Integration options and API maturity

Integration maturity is where the vendor differences bite hardest. If your architecture assumes a data warehouse pulling from all systems, MRI is the easiest to work with and Yardi requires more work. ARGUS integration typically involves scheduled exports rather than real-time APIs, which is fine for quarterly valuation cycles but limits real-time dashboarding. Custom middleware often sits between ARGUS and the rest of the stack.

09

What each platform cannot do

The gaps are where custom software earns its keep. Investor portals with LP-specific views, waterfall calculations, and document access almost always require a custom build or a dedicated fund admin platform. Deal pipeline and acquisition CRM are underserved by all three and typically run on Salesforce, HubSpot, or a custom tool. Portfolio-level analytics that combine ARGUS forecasts with Yardi or MRI actuals typically require a data warehouse and BI layer that no single vendor provides out of the box.

10

Common migration and switching decisions

The economics of switching between Yardi and MRI rarely justify the cost unless the current platform is genuinely blocking growth. What is more common is adding capabilities on top of the existing platform, a data warehouse, a BI layer, an ESG platform, an investor portal, rather than ripping and replacing. Switching ARGUS versions (AE vs Cloud) is more common than switching away from ARGUS, because the modelling language and lease library are hard to replicate.

11

How to evaluate for your portfolio

The strongest evaluations start with an internal requirements exercise, what does the AM function need to do in year 1, year 3, and year 5, and what does the tech stack need to support. Vendors then respond against that specification rather than pitching their preferred configuration. Reference calls with peer funds are the highest signal input, ask about implementation reality, support responsiveness, and hidden costs. Independent consultants and implementation partners can help structure the RFP and score responses without vendor bias.